Background To date, no immunological data on COVID-19 heterologous vaccination schedules
in humans have been reported. We assessed the immunogenicity and reactogenicity of …

Natural history studies have identified factors that predict evolution to multiple sclerosis or risk
of disability accumulation over time. Although these studies are based on large multicentre …

Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming
available in the past years. There is a need for a reference tool compiling current data to aid …

Background and purpose Information regarding multiple sclerosis (MS) patients with the 2019
novel coronavirus disease (COVID‐19) is scarce. The study objective was to describe the …

Importance Progression independent of relapse activity (PIRA) is the main event responsible
for irreversible disability accumulation in relapsing multiple sclerosis (MS). Objective To …

Background and objectives: Treatment of spasticity poses a major challenge given the
complex clinical presentation and variable efficacy and safety profiles of available drugs. We …

Background Global pandemic SARS-CoV-2 causes a prothrombotic state without fully
elucidated effects. This study aims to analyse and quantify the possible retinal microvascular …

Objetivo. Resumir la evidencia disponible respecto a la influencia de las comorbilidades en
la historia natural de la esclerosis múltiple. Desarrollo. Los pacientes con esclerosis …

Background: Population-based studies on neuromyelitis optica spectrum disorders (NMOSD)
are limited, and it is unclear whether the rates have changed with the implementation of …

Background and Objectives To explore whether time to diagnosis, time to treatment initiation,
and age to reach disability milestones have changed in patients with clinically isolated …